foxo4 dri senolytic human trial FOXO4-DRI UK | Peptide Research FOXO4-DRI induces keloid senescent fibroblast
FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases[v1] Cellular senescence and senolytics: the path to the clinic Nature Medicine FOXO4 DRI (FOX04 DRI) 10mg Peptide Luxe Peptides Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





